Latest Sanofi Stories
TARRYTOWN, N.Y. and PARIS, Jan. 26, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.
Call for Award Nominations to Recognize Innovation in Healthcare Marketing NEW YORK, NY (PRWEB) January 22, 2015 Entries are now being accepted for the
SAN DIEGO, Jan. 21, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Jean-Pierre Bizzari, M.D. to its Board of Directors. Dr.
TARRYTOWN, N.Y. and PARIS, Jan.
Primary efficacy endpoints met in two trials of alirocumab administered every four weeks TARRYTOWN, N.Y. and PARIS, Jan. 9, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
The increased adoption of insulin pens and growing number of diagnosed diabetics will drive the US market for modern insulin to over $17 billion by 2020, reports iData Research. Vancouver,
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparin CARLSBAD, Calif., Dec. 7, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).